The Royal Swedish Academy of Sciences has awarded Aaron Ciechanover, MD, DSc, the 2004 Nobel Prize in chemistry.
The Royal Swedish Academy of Sciences has awarded Aaron Ciechanover, MD, DSc, the 2004 Nobel Prize in chemistry.
Dr. Ciechanover, a scientist who receives funding from the Prostate Cancer Foundation, was recognized for his work on proteasome, a cellular machine that regulates the destruction of unneeded cell proteins. The proteasome is the target of the drug bortezomib (Velcade), which is being tested to treat prostate cancer and is approved to treat multiple myeloma.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.